Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Tolerance”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Not applicableUnknownNCT05068973
What this trial is testing

Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients

Who this might be right for
Lung Cancer
Hospital St. Joseph, Marseille, France 35
Not applicableLooking for participantsNCT05974475
What this trial is testing

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer

Who this might be right for
Lung Neoplasm Malignant
European Institute of Oncology 270
Not applicableActive Not RecruitingNCT04624256
What this trial is testing

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 226
Not applicableStudy completedNCT00818311
What this trial is testing

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Who this might be right for
Radiation ToleranceSkin AgingRhytids
L'Oreal 100
Early research (Phase 1)UnknownNCT03591302
What this trial is testing

Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.

Who this might be right for
Immune Tolerance
Stephan Busque 25
Not applicableStudy completedNCT01752751
What this trial is testing

Predicting Tolerance to Radiation Therapy in Older Adults With Cancer

Who this might be right for
Pre-treatment Loss of Independent Activities of Daily Living
UNC Lineberger Comprehensive Cancer Center 50
Post-approval studies (Phase 4)UnknownNCT02948699
What this trial is testing

A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients

Who this might be right for
Malignant Neoplasm of Nasopharynx
Zhejiang Cancer Hospital 114
Not applicableUnknownNCT02623647
What this trial is testing

A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Regina Elena Cancer Institute 150
Not applicableEnded earlyNCT02785692
What this trial is testing

Preoperative IMRT for Soft Tissue Sarcoma of the Extremities and Trunk: Low Rate of Wound Complications

Who this might be right for
Sarcoma
Balgrist University Hospital 67
Very early researchUnknownNCT03292445
What this trial is testing

Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation

Who this might be right for
Immune Tolerance
Samuel Strober 24
Large-scale testing (Phase 3)UnknownNCT03163979
What this trial is testing

Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Nanjing Medical University 300
Early research (Phase 1)Study completedNCT02515877
What this trial is testing

Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers

Who this might be right for
Cervical Cancer
Gustave Roussy, Cancer Campus, Grand Paris 15
Testing effectiveness (Phase 2)Ended earlyNCT00735345
What this trial is testing

Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Arbeitsgemeinschaft medikamentoese Tumortherapie 50
Not applicableStudy completedNCT03980977
What this trial is testing

Unusual Toxicity Induced by Radiotherapy

Who this might be right for
Cancer
Institut de Cancérologie de Lorraine 45
Early research (Phase 1)Study completedNCT03371004
What this trial is testing

DM-CHOC-PEN Plus Radiation for Brain Tumors

Who this might be right for
Advanced Cancer
DEKK-TEC, Inc. 19
Early research (Phase 1)Study completedNCT05989997
What this trial is testing

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Who this might be right for
Solid TumorPositron-Emission Tomography(PET)
SmartNuclide Biopharma 17
Testing effectiveness (Phase 2)Looking for participantsNCT06656598
What this trial is testing

Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Who this might be right for
Stage III NSCLC
Intergroupe Francophone de Cancerologie Thoracique 152
Not applicableUnknownNCT05433974
What this trial is testing

Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

Who this might be right for
RadiosensitivityCancerRadiation Toxicity
Centre Francois Baclesse, Luxembourg 200
Not applicableEnded earlyNCT01748591
What this trial is testing

Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice

Who this might be right for
Bowel Cleanliness
Ferring Pharmaceuticals 3,324
Testing effectiveness (Phase 2)Study completedNCT01761929
What this trial is testing

5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases

Who this might be right for
Solid Tumors With Oligometastatic Spread
University Health Network, Toronto 138
Load More Results